News Articles Tagged: Cancer Immunity

The Impact of IDO1 Inhibition by Epacadostat on Tumor Microenvironment

Examine how Epacadostat's inhibition of IDO1 reshapes the tumor microenvironment, enhancing anti-cancer immunity and offering new therapeutic avenues.

The Health Benefits of Lentinan: From Immunity to Cancer Support

Explore the diverse health benefits of Lentinan, a powerful compound from shiitake mushrooms. Learn about its immune-boosting effects and its role as an adjunct therapy in cancer care.

Enhancing Anti-Tumor Immunity: The Critical Role of 1-Methyl-D-tryptophan

Discover how 1-Methyl-D-tryptophan, by inhibiting IDO, enhances anti-tumor immunity by improving CD8+ T-cell function and reducing tumor volume. Learn about its application in cancer research.

Pegfilgrastim: Enhancing White Blood Cell Counts for Optimal Cancer Treatment

Learn how Pegfilgrastim boosts neutrophil production to enhance patient immunity during chemotherapy. A key pharmaceutical chemical for improving cancer treatment outcomes. NINGBO INNO PHARMCHEM CO.,LTD. discusses.

Thymosin Alpha-1: A Peptide for Enhanced Immunity and Advanced Therapies

Discover the science, applications, and benefits of Thymosin Alpha-1, a crucial peptide for immune system support, with roles in treating viral infections, cancers, and potential in managing immune deficiencies.

Dihydroartemisinin's Role in Enhancing Anti-Tumor Immunity: A New Frontier in Cancer Therapy

Examine how Dihydroartemisinin (DHA) supports the immune system in fighting cancer, exploring its impact on immune cells and its potential synergy with other treatments.

Thymopentin Acetate (TP-5): Enhancing Immunity and Therapeutic Outcomes - Insights from NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. explores the multifaceted benefits of Thymopentin Acetate (TP-5) in boosting immunity, aiding cancer treatment, and improving vaccine response.

The IL-33/ST2 Axis: A Crucial Target for Decitabine's Anti-Cancer Effects in Melanoma

Understanding the pivotal role of the IL-33/ST2 axis in mediating Decitabine's anti-melanoma efficacy and its implications for future therapies.

Epigenetic Control of Immunity: How Decitabine Modifies the Tumor Microenvironment

Delve into the epigenetic mechanisms by which Decitabine influences the tumor microenvironment, paving the way for enhanced anti-cancer immune responses.